pyrrolidine-2,4-dicarboxylic acid has been researched along with bucladesine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, JM; Harrison, PJ; Meller, R; Sharp, T | 1 |
| Kim, HS; Lee, YB; Lim, DK | 1 |
2 other study(ies) available for pyrrolidine-2,4-dicarboxylic acid and bucladesine
| Article | Year |
|---|---|
In vitro evidence that 5-hydroxytryptamine increases efflux of glial glutamate via 5-HT(2A) receptor activation.
Topics: Animals; Bucladesine; Calcium; Cell Line; Chromatography, High Pressure Liquid; Culture Media, Conditioned; Dicarboxylic Acids; Diuretics; Dose-Response Relationship, Drug; Furosemide; Glutamic Acid; Neuroglia; Neurotransmitter Uptake Inhibitors; Pyrrolidines; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2002 |
Effects of dehydroevodiamine exposure on glutamate release and uptake in the cultured cerebellar cells.
Topics: Alkaloids; Animals; Bucladesine; Cells, Cultured; Cerebellum; Dicarboxylic Acids; Drug Administration Schedule; Drug Synergism; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Male; Neuroglia; Neurons; Pyrrolidines; Rats; Rats, Sprague-Dawley | 2004 |